SignatureFD’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$184K Sell
655
-79
-11% -$20.8K ﹤0.01% 1148
2026
Q1
$196K Buy
734
+25
+4% +$6.77K ﹤0.01% 1019
2025
Q4
$178K Sell
709
-46
-6% -$12.2K ﹤0.01% 1025
2025
Q3
$217K Sell
755
-61
-7% -$16.3K ﹤0.01% 923
2025
Q2
$214K Buy
816
+171
+27% +$41.6K ﹤0.01% 886
2025
Q1
$150K Buy
645
+57
+10% +$13.8K ﹤0.01% 1011
2024
Q4
$135K Buy
588
+52
+10% +$11.9K ﹤0.01% 1068
2024
Q3
$120K Sell
536
-38
-7% -$8.35K ﹤0.01% 1134
2024
Q2
$117K Sell
574
-371
-39% -$75.5K ﹤0.01% 1094
2024
Q1
$206K Sell
945
-296
-24% -$65.2K ﹤0.01% 821
2023
Q4
$282K Buy
1,241
+265
+27% +$55.7K 0.01% 667
2023
Q3
$196K Sell
976
-114
-10% -$24K 0.01% 757
2023
Q2
$226K Sell
1,090
-116
-10% -$22.5K 0.01% 712
2023
Q1
$238K Sell
1,206
-289
-19% -$59.5K 0.01% 663
2022
Q4
$302K Buy
1,495
+131
+10% +$25.6K 0.01% 556
2022
Q3
$240K Sell
1,364
-119
-8% -$24.4K 0.01% 611
2022
Q2
$299K Buy
1,483
+114
+8% +$24.3K 0.01% 546
2022
Q1
$310K Sell
1,369
-15
-1% -$3.53K 0.01% 566
2021
Q4
$374K Buy
1,384
+65
+5% +$16.1K 0.01% 489
2021
Q3
$319K Buy
1,319
+115
+10% +$29K 0.01% 515
2021
Q2
$285K Buy
1,204
+14
+1% +$3.19K 0.01% 528
2021
Q1
$261K Buy
1,190
+238
+25% +$47.8K 0.01% 495
2020
Q4
$167K Buy
952
+9
+1% +$1.55K 0.01% 595
2020
Q3
$152K Sell
943
-2
-0.2% -$317 0.01% 577
2020
Q2
$135K Buy
945
+51
+6% +$7.06K 0.01% 580
2020
Q1
$97K Buy
894
+199
+29% +$28.7K 0.01% 649
2019
Q4
$101K Sell
695
-434
-38% -$62.7K 0.01% 703
2019
Q3
$163K Buy
1,129
+242
+27% +$35.3K 0.01% 471
2019
Q2
$132K Buy
887
+367
+71% +$51.2K 0.01% 527
2019
Q1
$68K Buy
520
+63
+14% +$7.76K 0.01% 772
2018
Q4
$50K Sell
457
-128
-22% -$17.1K ﹤0.01% 843
2018
Q3
$87K Sell
585
-7
-1% -$1.06K 0.01% 689
2018
Q2
$91K Sell
592
-41
-6% -$6.19K 0.01% 644
2018
Q1
$88K Buy
+633
New +$93K 0.01% 583
2016
Q4
Sell
-257
Closed -$30K 780
2016
Q3
$30K Buy
257
+98
+62% +$11.5K ﹤0.01% 684
2016
Q2
$18K Buy
159
+78
+96% +$8.39K ﹤0.01% 744
2016
Q1
$8K Sell
81
-56
-41% -$5.37K ﹤0.01% 891
2015
Q4
$15K Buy
137
+66
+93% +$6.81K ﹤0.01% 641
2015
Q3
$7K Buy
71
+16
+29% +$1.66K ﹤0.01% 757
2015
Q2
$6K Buy
55
+49
+817% +$5.1K ﹤0.01% 719
2015
Q1
$1K Sell
6
-58
-91% -$5.96K ﹤0.01% 889
2014
Q4
$6K Hold
64
﹤0.01% 579
2014
Q3
$6K Sell
64
-31
-33% -$2.8K ﹤0.01% 521
2014
Q2
$8K Buy
95
+31
+48% +$2.69K ﹤0.01% 491
2014
Q1
$5K Hold
64
﹤0.01% 534
2013
Q4
$5K Buy
+64
New +$5.46K ﹤0.01% 521

Other funds holding LH

SignatureFD's LH Position: Q2 2026 in Review

SignatureFD reduced its Labcorp (LH) stake by 11% in Q2 2026, selling an estimated $20.8K and leaving 655 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #1148.

SignatureFD first reported a position in LH in Q4 2013 and has held it in 46 quarters since. The position peaked at $374K in Q4 2021. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • SignatureFD held 655 shares of Labcorp worth $184K as of Q2 2026.
  • SignatureFD sold 79 Labcorp shares in Q2 2026, an estimated $20.8K.
  • Labcorp made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1148 holding.
  • SignatureFD first reported a position in Labcorp in Q4 2013 and has held it in 46 quarters since.
  • SignatureFD's Labcorp position peaked at $374K in Q4 2021.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.